NMDA receptors play an anti-aggregating role in human platelets

Thrombosis and Haemostasis

Volumn 76, Issue 1, 1996, Pages 84-87

  Franconi, Flavia ^a   Miceli, Mauro ^b   De Montis, Maria Graziella ^b   Crisafi, Elena Lupis ^b   Bennardini, Federico ^a   Tagliamonte, Alessandro ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; ARACHIDONIC ACID; DIZOCILPINE; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; BINDING AFFINITY; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; NERVE CELL; NORMAL HUMAN; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0030055385     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650527     Document Type: Article

References (27)

1. Colman RW, Marder VJ, Salzman EW, Hirsh J. Overview of hemostasis. In: "Hemostasis and thrombosis, basic principles and clinical practice". Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia: J. B. Lippincott Company 1994; 3-18.
2. Jamieson GA, Agrawal AK, Greco NJ, Tenner TE, Jones GD, Rice KC, Jacobson AE, White JG, Tandon NN. Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline. Biochem J, 1992; 285: 35-9.
3. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989; 29: 365-402.
4. Watkins JC. The NMDA receptor concept: origins and development. In: "The NMDA Receptor". Watkins JC and Collingridge GL, ed. Oxford, New York, Tokyo: IRL Press 1989; 1-17.
5. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature, 1987; 325: 529-31.
6. McDonald JW, Johnston MV. Physiological and pathophysiological role of excitatory amino acids during central nervous system development. Brain Res Rev 1990; 15: 41-70.
7. Daw NW, G. Stein PS, Fox K. The role of NMDA receptors in information processing. Annu Rev Neurosci 1993; 16: 207-22.
8. Olney JW. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 1990; 30: 47-71.
9. Erdo SL. Excitatory amino acids receptors in the mammalian periphery. Trends Pharmacol Sci 1991; 12: 426-9.
10. Almazov VA, Popov YG, Gorodinskii AI, Mikhailova OA, Dambinova SA, Gurevich VS. Sites of high affinity binding of L-[3H]-glutamic acid in human platelets. New type of platelet receptors? Biokhimiya 1988; 53: 848-52.
11. Wong EHF, Kemp JA, Pristley T, Knight AR, Woodruff GN, Iversen LL. The anticonvulsant MK-801 is a potent N-methyl-D-aspartale antagonist. Proc Natl Acad Sci 1986; 83: 7104-8.
12. Jamieson GA, Raulli RE, Jackson B. Phencyclidine inhibits epinephrine-stimulated platelet aggregation independently of high affinity N-methyl-D-aspartate (NMDA)-type glutamate receptors. Biochim Biophys Acta 1994; 1224: 175-80.
13. Born GUR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-86.
14. Franconi F, Miceli M, Bennardini F, Mattana A, Covarrubias J, Seghieri G. Taurine potentiates the antiaggregating action of aspirin and indomethacyn, in: Taurine: nutritional value and mechanism of action. Lombardini JB, Schaffer SW, Azuma J (Ed). Plenum Press, N. Y. London 1992, pp. 181-6.
15. Bristow DR, Bowery NG, Woodruff GN. Light microscopic autoradiographic localisation of [3H]-glycine and [3H]-strichnine binding sites in rat brain. Europ J Pharmacol 1986; 126: 303-7.
16. 3H]-CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Europ J Pharmacol 1991; 192: 19-24.
17. Davies JD, Francis AA, Jones AW, Watkins JC. 2-Amino-5-phosphonovalerate (2-APV), a potent and selective antagonist of amino acid induced and synaptic excitation. Neurosci Lett 1981; 21: 77-81.
18. Snell LD, Tabakoff B, Hoffman PL. Radioligand binding to the N-methyl-D-aspartate receptor/ionophor complex: alterations by ethanol in vitro and by chronic in vivo ethanol injestion. Brain Res 1993; 602: 91-8.
19. Levin RM, Weiss B. Selective binding of antipsychotics and other psychoactive agents to the calcium dependent activator of cyclic nucleotide phosphodiesterase. J Parmacol Exp Ther 1979; 208: 454-9.
20. Foster AC, Wong HF. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. British J Pharmacol 1987; 91: 403-9.
21. 2+ flux in human platelet activation. Adv Exp Med Biol 1985; 192: 127-44.
22. Crawford NV, Scrutton MC. Biochemistry of the blood platelet. In: Hemostasis and Thrombosis, 2nd edn. Bloom AL, Thomas DP ed. Edinburgh: Churchill Livingstone 1987; 47-77.
23. Bushfield M, McNicol A, MacIntyre DA. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. Biochem J 1985; 232: 267-71.
24. Cooper DMF, Mons N, Karpen JW. Adenylyl cyclasc and the interaction between calcium and cAMP signalling. Nature 1995; 374: 421-4.
25. 2+ ions. Europ J Biochem 1986; 154: 451-6.
26. Grigorian GY, Resink TJ, Stucki S, Buhler FR. Calmodulin regulation of adenylyl cyclase activity in human platelet membranes. Cell Calcium 1986; 7: 261-73.
27. 2+ and calmodulin on adenylyl cyclase activity in plasma membranes derived from neural and non-neural cells. Cell Calcium 1992; 13: 107-21.